Severe hypomagnesemia and secondary hypocalcemia associated with vonoprazan in a patient with type 2 diabetes
Abstract
Hypomagnesemia is a well-known complication of long-term proton pump inhibitor usage; the stronger acid-suppressive effect of potassium-competitive acid blockers (P-CABs) may increase the risk of hypomagnesemia to a similar or greater extent. However, reports of P-CAB-associated hypomagnesemia are scarce. A 78-year-old Japanese man with a history of type 2 diabetes and myocardial infarction, who was receiving low-dose aspirin and long-term vonoprazan, presented with epigastric discomfort. Laboratory testing revealed significant hypocalcemia, hypomagnesemia, and low intact parathyroid hormone levels, which were consistent with functional hypoparathyroidism. Electrocardiogram (ECG) showed QTc prolongation and frequent premature ventricular contractions. Urinary magnesium excretion was low, suggesting impaired intestinal magnesium absorption rather than renal loss. Vonoprazan was discontinued, and magnesium and calcium supplementation was initiated. Electrolyte abnormalities normalized by day 3, and ECG changes subsequently resolved. No recurrence occurred after switching to an H2-receptor antagonist. This case demonstrates severe hypomagnesemia and secondary hypocalcemia associated with long-term use of vonoprazan. P-CABs are often used with low-dose aspirin for ulcer prophylaxis against atherosclerotic diseases in patients with diabetes. Clinicians should be aware of hypomagnesemia as an adverse effect of P-CABs and consider periodic monitoring of serum magnesium levels,…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- The Prediction of the In Vitro Release Curves for PLGA-Based Drug Delivery Systems with Neural Networks
- Promising Ursolic Acid as a Novel Antituberculosis Agent: Current Progress and Challenges
- Proof of principle concept for the analysis and functional prediction of rare genetic variants in the CYP2C19 and CYP2D6 genes
- Fabrication, characterization, and docking studies of furosemide-loaded nanosponges using the emulsion solvent diffusion method
- The Effect of Concomitant Administration of Proton Pump Inhibitors on the Pharmacokinetics of CDK4/6 Inhibitors in Rats: Implications for the Evaluation of Hepatic and Transporter-Mediated Drug–Drug Interactions
- Mining the Metabolic Capacity of Clostridium sporogenes Aided by Machine Learning
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.